期刊文献+

临床药师在静注人免疫球蛋白使用管理中的药学监控 被引量:8

原文传递
导出
摘要 目的对医院紧缺血制品如静注人免疫球蛋白(IVIg)的使用实行临床药师审核制,确保紧缺药品严格按照适应症使用。方法药师进入临床科室,对申请者医嘱进行适宜性审核,符合适应症使用的申请予以发放药品,反之,说明理由,和医生协商后不予使用。结果如何准确判断用药的合理性是药师审核中遇到的最大难题,需要结合循证学依据,总结临床实际情况作出合适判断。结论通过药师干预,有效缓解紧缺血制药品供不应求的矛盾,确保急需药品在临床使用合理。
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第3期239-240,共2页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献4

  • 1SINISALO M, AITTONIEMI J, KAYHTY H, et al. Vaccination a- gainst infections in chronic lymphocytic leukemia [ J]. Leuk Lymphoma, 2003, 44(4) :649-652.
  • 2DUHEM C, DICATO M A, RIES F. Side-effects Of intravenous immune globulins [J].Clin Exp Immul, 1994, 97(suppl 1 ) :79- 83.
  • 3ASHLEY A V, VINH C A M, TOYODA M, et al. Safety and ad- verse events profiles of intravenous gammaglobulin products used for immunomodulation: A single-center experience [J]. Clin J Am Soc Nephrol, 2006, 1 : 844-852.
  • 4ORANGE J S, HOSSNY E M, WEILER C R, et al. Use of intravenous immunoglobulin in human isease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology[J]. J Allergy Clin lmmunol, 2006, 117 (4) :525-553.

同被引文献78

  • 1索涛,范慧,陈国忠.病毒性肺炎治疗的研究进展[J].武汉大学学报(医学版),2020(3):378-383. 被引量:18
  • 2王新兵.大剂量丙种球蛋白冲击疗法治疗急性重症病毒性肺炎的效果[J].世界临床医学,2017,11(9):56-56. 被引量:1
  • 3黄文琴.1例静脉射注丙种球蛋白致过敏反应的观察与护理[J].现代医药卫生,2006,22(24):3832-3832. 被引量:1
  • 4Hartung HP, Mouthon L, Ahmed R, et al. Clinical applica- tions of intravenous immunoglobulins (IVIg) - beyond immu- nodeficiencies and neurology[J]. Clin Exp Immunol, 2009, 158 (Suppl 1) .. 23 33.
  • 5Imbach P, Barandun S, d' Apuzzo V, et al. High-dose intrave- nous gammaglobulin for idiopathic tbrombocytopenic purpura in childhood[J]. Lancet, 1981,1 (8232) : 1228-1231.
  • 6Looney RJ , Huggins J. Use of intravenous imrnunoglobulin G (IVIG)[J]. Best Pract Res Clin Haematol, 2006, 19 (1) : 3- 25.
  • 7Provan D, Nokes JCN, Agrawal S, et al. IVIG Guideline De- velopment Group of the IVIg Expert Working Group Clinical Guidelines for Immunoglobulin Use[M]. 2nd ed. Scotland: Department of Health, 2009.
  • 8Smith SD, Dennington PM, Cooper A. The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review [J]. Australas J Dermatol, 2010,51(4): 227-237.
  • 9Anderson D, Ali K, Blanchette V, et al. Guidelines on the Use of Intravenous Immune Globulin for Hematologic Condi- tions [J]. Transfus Med Rev. 2007, 21(2 Suppl 1):$9-56.
  • 10Orange JS, Hossnye M, Weiler C R, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology[J]. J Allergy Clin Immunol, 2006,117(4 suppl) : 525 553.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部